Literature DB >> 16490594

Cytogenetic aberrations in immortalization of esophageal epithelial cells.

Hao Zhang1, Yuesheng Jin, Xuehua Chen, Charlotte Jin, Simon Law, Sai-Wah Tsao, Yok-Lam Kwong.   

Abstract

To define the early cytogenetic events important in esophageal carcinogenesis, we immortalized normal esophageal epithelial cells by overexpression of human papillomavirus type 16 E6/E7 (HPV16E6/E7) and human telomerase reverse transcriptase (hTERT), and characterized the chromosomal abnormalities serially before and after cellular immortalizaiton. During crisis, most cells had simple nonclonal karyotypic changes with cytogenetic divergence. Mitotically unstable chromosomes (i.e., telomere association and dicentric chromosomes) were the most common aberrations. After crisis, the karyotypic patterns were more convergent with nonrandom clonal changes. A few clones dominated the culture. Gain of chromosome 20q was consistently observed in four HPVE6/E7 immortalized esophageal lines, whereas amplification of chromosome 5q was preferentially found in hTERT immortalized cells. In addition, chromosomal aberrations of immortalized cells, including del(3p) and centromere rearrangements, were similar to those observed in esophageal cancer. Furthermore, in E6/E7-expressing cells, the frequency of negative telomere termini and anaphase bridges were high during crisis and low after crisis. These findings suggested that telomere dysfunction might be an important cause of cellular crisis, and the resultant chromosomal aberrations, mainly amplification of chromosome 20q or 5q, might be early genetic events required in esophageal cell immortalization. These alterations might be valuable models for further study of molecular mechanisms contributing to esophageal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490594     DOI: 10.1016/j.cancergencyto.2005.07.016

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  21 in total

1.  Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma.

Authors:  W Zhang; R Hong; L Xue; Y Ou; X Liu; Z Zhao; W Xiao; D Dong; L Dong; M Fu; L Ma; N Lu; H Chen; Y Song; Q Zhan
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

2.  Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes.

Authors:  Jacqueline Brown; Hannelie Bothma; Robin Veale; Pascale Willem
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

3.  The absence of human papillomavirus in esophageal squamous cell carcinoma in East China.

Authors:  Haohua Teng; Xiaojing Li; Xiuping Liu; Jie Wu; Jie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Identification of genomic alterations in oesophageal squamous cell cancer.

Authors:  Yongmei Song; Lin Li; Yunwei Ou; Zhibo Gao; Enmin Li; Xiangchun Li; Weimin Zhang; Jiaqian Wang; Liyan Xu; Yong Zhou; Xiaojuan Ma; Lingyan Liu; Zitong Zhao; Xuanlin Huang; Jing Fan; Lijia Dong; Gang Chen; Liying Ma; Jie Yang; Longyun Chen; Minghui He; Miao Li; Xuehan Zhuang; Kai Huang; Kunlong Qiu; Guangliang Yin; Guangwu Guo; Qiang Feng; Peishan Chen; Zhiyong Wu; Jianyi Wu; Ling Ma; Jinyang Zhao; Longhai Luo; Ming Fu; Bainan Xu; Bo Chen; Yingrui Li; Tong Tong; Mingrong Wang; Zhihua Liu; Dongxin Lin; Xiuqing Zhang; Huanming Yang; Jun Wang; Qimin Zhan
Journal:  Nature       Date:  2014-03-16       Impact factor: 49.962

5.  Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma.

Authors:  Marco K C Hui; Kenneth K Y Lai; Kwok Wah Chan; John M Luk; Nikki P Lee; Yvonne Chung; Leo C Cheung; Gopesh Srivastava; Sai Wah Tsao; Johnny C Tang; Simon Law
Journal:  Med Oncol       Date:  2011-11-16       Impact factor: 3.064

6.  Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.

Authors:  Jun Dong; Bo-hang Zeng; Li-hua Xu; Jun-ye Wang; Man-zhi Li; Mu-sheng Zeng; Wan-li Liu
Journal:  J Transl Med       Date:  2010-09-03       Impact factor: 5.531

7.  Abrogated expression of DEC1 during oesophageal squamous cell carcinoma progression is age- and family history-related and significantly associated with lymph node metastasis.

Authors:  V C L Wong; J M Y Ko; R Z Qi; P J Li; L D Wang; J-L Li; Y P Chan; K W Chan; E J Stanbridge; M L Lung
Journal:  Br J Cancer       Date:  2011-02-15       Impact factor: 7.640

8.  SAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinoma.

Authors:  H L Lung; O Y Man; M C Yeung; J M Y Ko; A K L Cheung; E W L Law; Z Yu; W H Shuen; E Tung; S H K Chan; D K Bangarusamy; Y Cheng; X Yang; R Kan; Y Phoon; K C Chan; D Chua; D L Kwong; A W M Lee; M F Ji; M L Lung
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

9.  Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma.

Authors:  Marco K C Hui; Kenneth K Y Lai; Kwok Wah Chan; John M Luk; Nikki P Lee; Yvonne Chung; Leo C M Cheung; Gopesh Srivastava; Sai Wah Tsao; Johnny C Tang; Simon Law
Journal:  Med Oncol       Date:  2012-04-19       Impact factor: 3.064

10.  ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness.

Authors:  Qingyu Luo; Xiaowei Wu; Wan Chang; Pengfei Zhao; Yabing Nan; Xiaolin Zhu; Jonathan P Katz; Dan Su; Zhihua Liu
Journal:  Cell Death Differ       Date:  2019-12-12       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.